neuropathy center header The Columbia Neuropathy Research Center CUMC Department of Neurology, Columbia University

  Tel: 212-305-6035

Research & Clinical Trials




New Study:



Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)



This is a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group 3-arm study to investigate 2 different doses of subcutaneous (SC) IgPro20 compared with placebo for maintenance treatment of patients with CIDP.

The overall study duration is up to 52 weeks.

» Click here for additional information

For more information and to see if you qualify, please call:


The Columbia Neuropathy Research Center
The Neurological Institute
710 W 168th St, 2nd floor
New York, NY 10032
Tel. 212-305-6035



New Study:



Idiopathic Painful Peripheral Neuropathy Research Study



If you experience numbness, tingling, burning or pain in your legs, toes or feet, you may have Peripheral Neuropathy. Our center is currently looking volunteers to participate in a study of an investigational medication that may help treat your Painful Neuropathy.

You may be eligible to participate if you:


  • Are between the ages of 18-80
  • Have had symptoms of peripheral neuropathy for at least 6 months, caused by a neuropathy not caused by diabetes or other defined causes
  • Have moderately severe pain
  • Are in otherwise good health

» Click here for additional information.

For more information and to see if you qualify, please call:


The Columbia Neuropathy Research Center
The Neurological Institute
710 W 168th St, 13th floor
New York, NY 10032
Tel. 212-305-6035



New Study:



Lambert-Eaton Myasthenic Syndrome



A clinical research study evaluating an investigational drug for LEMS The motus study is being conducted in approximately 30 patients from 20 research sites in different countries. The purpose of the study is to see if the study drug can improve your muscle strength and to see if it is safe and effective for use in patients with Lambert-Eaton Myasthenic Syndrome (LEMS).

Talk to your doctor today to see if you may be eligible to participate in the study.

Criteria for participating in the study:



  • 18 years or older
  • Clinically diagnosed with LEMS
  • Willing to perform all study procedures as is physically possible
  • Willing to provide consent to have all procedures completed, as explained to you by qualified staff

Study participation includes, at no charge to you:



  • Study visits with a medical professional
  • Investigational drug
  • Study procedures and tests
  • Compensation for travel may be provided

You may be eligible to participate in the study even if you are already taking medication(s) for LEMS.

For a complete list of eligibility criteria consult your doctor

» Download flyer (pdf)

For more information and to see if you qualify, please call Stacy Mano:


The Columbia Neuropathy Research Center
The Neurological Institute
710 W 168th St, 13th floor
New York, NY 10032
Tel. 212-305-6035
Home | Faculty and Staff | Research & Clinical Trials | What is Neuropathy? | Contact Information | Directions | How You Can Help
©2006-2011 The Neurological Institute of New York • At Columbia University Medical Center
The Columbia Neuropathy Research Center. 710 W 168th St, New York, NY 10032. Phone: 212-305-6035
Updated March 14, 2013 • Comments | Sitemap